GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (WAR:BAY) » Definitions » Cyclically Adjusted PB Ratio

Bayer AG (WAR:BAY) Cyclically Adjusted PB Ratio : 0.65 (As of May. 24, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bayer AG Cyclically Adjusted PB Ratio?

As of today (2024-05-24), Bayer AG's current share price is zł120.84. Bayer AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was zł187.10. Bayer AG's Cyclically Adjusted PB Ratio for today is 0.65.

The historical rank and industry rank for Bayer AG's Cyclically Adjusted PB Ratio or its related term are showing as below:

WAR:BAY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.61   Med: 2.31   Max: 6.28
Current: 0.64

During the past years, Bayer AG's highest Cyclically Adjusted PB Ratio was 6.28. The lowest was 0.61. And the median was 2.31.

WAR:BAY's Cyclically Adjusted PB Ratio is ranked better than
82.39% of 687 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs WAR:BAY: 0.64

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bayer AG's adjusted book value per share data for the three months ended in Mar. 2024 was zł154.676. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is zł187.10 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bayer AG Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted PB Ratio Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.21 1.42 1.30 1.20 0.79

Bayer AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 1.20 1.07 0.79 0.66

Competitive Comparison of Bayer AG's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted PB Ratio falls into.



Bayer AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bayer AG's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=120.84/187.1
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bayer AG's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=154.676/125.0381*125.0381
=154.676

Current CPI (Mar. 2024) = 125.0381.

Bayer AG Quarterly Data

Book Value per Share CPI Adj_Book
201406 123.474 99.543 155.099
201409 121.553 99.823 152.258
201412 115.841 99.543 145.511
201503 109.912 99.717 137.822
201506 116.930 100.417 145.600
201509 117.900 100.417 146.808
201512 123.508 99.717 154.871
201603 122.923 100.017 153.675
201606 119.277 100.717 148.080
201609 122.683 101.017 151.856
201612 149.508 101.217 184.694
201703 167.998 101.417 207.127
201706 171.416 102.117 209.892
201709 210.501 102.717 256.244
201712 203.498 102.617 247.961
201803 212.848 102.917 258.597
201806 231.898 104.017 278.762
201809 246.852 104.718 294.754
201812 219.828 104.217 263.746
201903 227.933 104.217 273.470
201906 202.209 105.718 239.164
201909 202.321 106.018 238.619
201912 209.839 105.818 247.954
202003 214.668 105.718 253.900
202006 160.695 106.618 188.458
202009 147.472 105.818 174.259
202012 148.407 105.518 175.862
202103 164.568 107.518 191.385
202106 146.331 108.486 168.658
202109 146.246 109.435 167.098
202112 149.119 110.384 168.916
202203 164.784 113.968 180.790
202206 160.623 115.760 173.496
202209 163.318 118.818 171.868
202212 164.156 119.345 171.987
202303 174.861 122.402 178.626
202306 159.988 123.140 162.454
202309 142.379 124.195 143.346
202312 143.510 123.773 144.977
202403 154.676 125.038 154.676

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bayer AG  (WAR:BAY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bayer AG Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (WAR:BAY) Business Description

Industry
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (WAR:BAY) Headlines

No Headlines